Biotechs are back as another early stage biotech, Keros Therapeutics (KROS), plans to take on the IPO market in the week ahead, following last week's successful debut of Zentalis Pharmaceuticals (ZNTL). ...read more
Three IPOs raised a combined $426 million this week, all pricing below the midpoint and finishing below issue. On average they returned a disappointing -13.5%.
Despite lopping $1 billion off of its proposed valuation, Germany-based BioNTech...read more
HBT Financial, a family-owned bank with 64 branches in central and northeastern Illinois, raised $133 million by offering 8.3 million shares at $16, below the range of $17 to $19. HBT Financial plans to list on the Nasdaq under the symbol HBT. Keefe Bruyette...read more
Two of the largest-ever biotech IPOs by market cap are scheduled for the week ahead. They are joined by an Illinois bank. The three deals plan to raise a combined $550 million. Germany-based BioNTech (BNTX) is targeting $251 million at a...read more
US IPO Week Ahead: Another biotech plans to take on the IPO market
Biotechs are back as another early stage biotech, Keros Therapeutics (KROS), plans to take on the IPO market in the week ahead, following last week's successful debut of Zentalis Pharmaceuticals (ZNTL). ...read more
US IPO Weekly Recap: Two big biotechs and a bank squeeze through the IPO window
Three IPOs raised a combined $426 million this week, all pricing below the midpoint and finishing below issue. On average they returned a disappointing -13.5%. Despite lopping $1 billion off of its proposed valuation, Germany-based BioNTech...read more
Illinois bank HBT Financial prices IPO below the range at $16
HBT Financial, a family-owned bank with 64 branches in central and northeastern Illinois, raised $133 million by offering 8.3 million shares at $16, below the range of $17 to $19. HBT Financial plans to list on the Nasdaq under the symbol HBT. Keefe Bruyette...read more
US IPO Week Ahead: 2 billion-dollar biotechs and a bank
Two of the largest-ever biotech IPOs by market cap are scheduled for the week ahead. They are joined by an Illinois bank. The three deals plan to raise a combined $550 million. Germany-based BioNTech (BNTX) is targeting $251 million at a...read more